{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/multiple-myeloma/management/suspected-multiple-myeloma/","result":{"pageContext":{"chapter":{"id":"da1a6baa-3eff-5249-bb76-6d086063c369","slug":"suspected-multiple-myeloma","fullItemName":"Scenario: Suspected multiple myeloma","depth":2,"htmlHeader":"<!-- begin field 8f0ec9fe-f38c-4ecb-bbec-1a88055cb429 --><h2>Scenario: Suspected multiple myeloma</h2><!-- end field 8f0ec9fe-f38c-4ecb-bbec-1a88055cb429 -->","summary":"Covers the management of a person with suspected multiple myeloma, including how to investigate and when to refer or admit to hospital.","htmlStringContent":"<!-- begin item 15c6d3e1-bdac-4779-98fc-a7ce4926f5d0 --><!-- begin field ece22587-3d95-4494-a42c-acd900adf521 --><p>From age 18 years onwards.</p><!-- end field ece22587-3d95-4494-a42c-acd900adf521 --><!-- end item 15c6d3e1-bdac-4779-98fc-a7ce4926f5d0 -->","topic":{"id":"a3257bde-777f-5b48-80cd-28a6de5401b7","topicId":"d449062b-fe98-40a2-bc4d-741f0b91c31d","topicName":"Multiple myeloma","slug":"multiple-myeloma","lastRevised":"Last revised in January 2021","chapters":[{"id":"001bce70-f61f-5905-b9a0-76e49dc2928b","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"a4e4ac31-e5c3-5d0d-ba8e-e28d748b38a8","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"d731856b-56b9-5d81-9db1-6e0380152383","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"288251ee-9e56-550b-bb07-75c191dd88bb","slug":"changes","fullItemName":"Changes"},{"id":"972750f6-1493-51ac-bb67-61a883caef31","slug":"update","fullItemName":"Update"}]},{"id":"9ee3d2ca-5de2-5a81-be8d-5389cb6b96fb","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"02fc2e8c-0154-52e2-81b7-13f9f7ae4157","slug":"goals","fullItemName":"Goals"},{"id":"297bf476-1f3c-5477-859b-fc44c3d58cdd","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"ca441620-7e21-5b08-9340-cca6210d21e9","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"23d46a0d-5d23-5d38-a2d7-817babead45a","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"7f4644ec-a108-52f6-874b-8644bd8da047","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"c6fdac6a-e178-59a4-bcb7-a22337d627a4","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"c45f4611-e831-51b1-ae27-0421b247f510","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"7e70c907-9e94-5f79-b9bb-ba6799a19ccd","slug":"definition","fullItemName":"Definition"},{"id":"64fa3b9a-e0f1-5f2c-aa6b-99ca7f657bb9","slug":"prevalence","fullItemName":"Prevalence"},{"id":"222268d1-82ef-5947-9a94-81c9475bd101","slug":"risk-factors","fullItemName":"Risk Factors"},{"id":"f2cd915a-2200-5a59-9f4b-e92d4e9721d6","slug":"prognosis","fullItemName":"Prognosis"},{"id":"b84e32aa-3d7d-5e4b-a3d8-9c8cc506b4a9","slug":"complications","fullItemName":"Complications"}]},{"id":"cd2396e2-8290-5f66-ad0f-871bfebc83dd","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"d1d186e7-f167-55b0-a9ba-20bc6df07ce9","slug":"when-should-i-suspect-multiple-myeloma","fullItemName":"When should I suspect multiple myeloma?"},{"id":"8116b468-694e-5fa4-aa60-09f23bc088e0","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"46717c89-6886-52dc-8e80-d8fb592c32b2","fullItemName":"Management","slug":"management","subChapters":[{"id":"da1a6baa-3eff-5249-bb76-6d086063c369","slug":"suspected-multiple-myeloma","fullItemName":"Scenario: Suspected multiple myeloma"},{"id":"c51edfd3-b143-5dfe-b734-2f46b572a5de","slug":"confirmed-multiple-myeloma","fullItemName":"Scenario: Confirmed multiple myeloma"},{"id":"1544f647-8ce2-51e4-adee-9cb61fc46ae1","slug":"end-stage-multiple-myeloma","fullItemName":"Scenario: End-stage multiple myeloma"}]},{"id":"375c8b98-56b6-5c85-a182-36856a3db2ca","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"b088260f-8cf4-5102-b99d-ab78d3ac71d3","slug":"analgesia","fullItemName":"Analgesia"}]},{"id":"ddabb890-df48-5057-a56f-32666fa74e9a","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"9764188e-1795-5b4f-8cdf-b70befc3fe0d","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"aef9e65b-4f13-546f-adbc-19654498aa31","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"79a1401a-ca39-5eff-ab8b-482281e9741f","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b84ca8eb-2866-56cb-b7a1-ecb59575fddc","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"592f1670-1381-587b-baec-8618a8caf851","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"e6e2cada-c7c4-5f01-bf87-9cecee0c53f0","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"6b485c3d-36d7-556a-993b-3311a38b7bf6","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"46717c89-6886-52dc-8e80-d8fb592c32b2","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"09ec4602-6a28-5aaa-bbc4-9555659b368e","slug":"how-should-i-manage-a-person-with-suspected-multiple-myeloma","fullItemName":"How should I manage a person with suspected multiple myeloma?","depth":3,"htmlHeader":"<!-- begin field 7a5db19f-8875-4e12-8d27-133f5192781d --><h3>How should I manage a person with suspected multiple myeloma?</h3><!-- end field 7a5db19f-8875-4e12-8d27-133f5192781d -->","summary":null,"htmlStringContent":"<!-- begin item 93427d57-522e-4faa-a60a-52525103d2cd --><!-- begin field 512ea70e-dc10-45c4-a142-63845da3cb4e --><ul><li><strong>Arrange urgent hospital admission for people with symptoms of <a class=\"topic-reference internal-reference\" href=\"/topics/multiple-myeloma/diagnosis/when-should-i-suspect-multiple-myeloma/\">spinal cord compression</a>.  </strong><ul><li>For more information, see the section on <a class=\"topic-reference external-reference\" href=\"/topics/back-pain-low-without-radiculopathy/diagnosis/red-flag-symptoms-signs/\">Red flag symptoms and signs</a> in the CKS topic <a class=\"topic-reference external-reference\" href=\"/topics/back-pain-low-without-radiculopathy/\">Back pain - low (without radiculopathy)</a>.</li></ul></li><li><strong>If urgent admission is not indicated:</strong><ul><li><strong>For people aged 60 years or older with persistent bone pain, particularly back pain, or unexplained fracture offer investigations including:</strong><ul><li>A full blood count, serum calcium, and plasma viscosity or erythrocyte sedimentation rate (ESR).</li></ul></li><li><strong>For people aged 60 years or older with hypercalcaemia or leukopenia, and a presentation consistent with possible myeloma offer investigations including:</strong><ul><li>Very urgent (within 48 hours) serum electrophoresis, serum-free light-chain assay, and Bence-Jones protein urine assessment.</li></ul></li><li><strong>For people whose plasma viscosity, ESR, or incidental findings on blood tests and presentation are consistent with possible myeloma consider:</strong><ul><li>Very urgent (within 48 hours) serum electrophoresis, serum-free light-chain assay, and Bence-Jones protein urine assessment.</li></ul></li><li><strong>Be aware that serum/urine electrophoresis is negative in 1–5% of people with multiple myeloma,</strong> who have a 'non-secretory' form of the disease that produces no serum M protein or urinary Bence-Jones protein.</li><li><strong>Also consider the following additional investigations to help confirm the diagnosis of multiple myeloma:</strong><ul><li>Peripheral blood film — to look for rouleaux (aggregations of red blood cells), which might suggest underlying paraproteinaemia.</li><li>Serum urea, creatinine, electrolytes, and liver function tests — to detect renal impairment, raised uric acid from increased tumour cell turnover, and to determine total protein concentration, which is usually raised in multiple myeloma.</li><li>X-rays of symptomatic areas for people with bone pain — to rule out pathological fractures.</li></ul></li></ul></li><li><strong>Arrange urgent hospital admission for people in whom investigations reveal moderate to severe hypercalcaemia (corrected calcium of 2.9 mmol/L or higher) or acute kidney injury.</strong><ul><li>For more information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/acute-kidney-injury/\">Acute kidney injury</a> and <a class=\"topic-reference external-reference\" href=\"/topics/hypercalcaemia/\">Hypercalcaemia</a>.</li></ul></li><li><strong>For all other people, arrange urgent referral to a haematologist (within 2 weeks using a suspected cancer pathway) for further investigations to confirm the diagnosis if serum and/or urine protein electrophoresis suggest myeloma.</strong></li></ul><!-- end field 512ea70e-dc10-45c4-a142-63845da3cb4e --><!-- end item 93427d57-522e-4faa-a60a-52525103d2cd -->","subChapters":[{"id":"b18a5f9f-18f0-5610-9d02-8f10984550f3","slug":"secondary-care-investigations","fullItemName":"Secondary care investigations","depth":4,"htmlHeader":"<!-- begin field bcfd6e6c-510a-4a24-9843-13adc1583503 --><h4>Secondary care investigations</h4><!-- end field bcfd6e6c-510a-4a24-9843-13adc1583503 -->","summary":null,"htmlStringContent":"<!-- begin item 7f7612ed-5d69-4e48-ad8e-2f2a4df82003 --><!-- begin field a2eb50d2-f37e-493e-8ed7-4c8e8a230247 --><p><strong>Investigations carried out in secondary care to confirm the diagnosis of multiple myeloma may include:</strong></p><ul><li>Immunofixation of serum and urine, to confirm the presence of a paraprotein.</li><li>Bone marrow aspirate and trephine biopsy, with plasma cell phenotyping, to confirm the presence of monoclonal plasma cells in the bone marrow.</li><li>Magnetic resonance imaging (MRI).<ul><li>This is the gold standard to determine the extent of myeloma bone disease. Dedicated spine MRI is also used to investigate possible spinal cord compression.</li><li>If MRI is unsuitable or is declined by the person, low-dose computed tomography (CT) can be performed.</li><li>Plain X-rays of the spine, skull, chest, pelvis, and bones of the upper limbs are sometimes used if MRI and low-dose CT are unsuitable or are declined by the person.</li></ul></li><li>Further tests to estimate tumour burden and prognosis may include:<ul><li>Fluorescence in situ hybridization (FISH) analysis of bone marrow aspirate.</li><li>Serum beta-2 microglobulin concentration.</li><li>Next-generation DNA sequencing.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/multiple-myeloma/references/\">Bird, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/multiple-myeloma/references/\">Moreau, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/multiple-myeloma/references/\">Caers, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/multiple-myeloma/references/\">NICE, 2018</a>]</p><!-- end field a2eb50d2-f37e-493e-8ed7-4c8e8a230247 --><!-- end item 7f7612ed-5d69-4e48-ad8e-2f2a4df82003 -->","subChapters":[]},{"id":"fc69d272-25fc-5902-8229-8efe9f66b0e3","slug":"basis-for-recommendation-ce0","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 54407748-ccc4-48c5-b3dd-4371b57197d7 --><h4>Basis for recommendation</h4><!-- end field 54407748-ccc4-48c5-b3dd-4371b57197d7 -->","summary":null,"htmlStringContent":"<!-- begin item ce033042-5494-4cdb-b0fb-e47d87abf1ba --><!-- begin field 5c918244-29c0-4b6d-885d-bc6b5050db37 --><p>The recommendations on management of a person with suspected multiple myeloma are largely based on expert opinion in the National Institute for Health and Care Excellence (NICE) guidelines <em>Suspected cancer: recognition and referral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/multiple-myeloma/references/\">NICE, 2015a</a>] and <em>Myeloma: diagnosis and management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/multiple-myeloma/references/\">NICE, 2018</a>], the British Committee for Standards in Haematology (BCSH) <em>Guidelines for the diagnosis and management of multiple myeloma</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/multiple-myeloma/references/\">Bird, 2014</a>], <em>Multiple myeloma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/multiple-myeloma/references/\">Moreau, 2017</a>], the European Myeloma Network <em>Recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/multiple-myeloma/references/\">Caers, 2018</a>], the National Comprehensive Cancer Network Guidelines <em>Insights: multiple myeloma</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/multiple-myeloma/references/\">Kumar, 2019</a>], and a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/multiple-myeloma/references/\">Smith, 2013</a>].</p><ul><li>The recommendations on when to consider investigations including very urgent serum electrophoresis, serum-free light-chain assay, and Bence-Jones protein urine assessment are based on the NICE guideline <em>Suspected cancer: recognition and referral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/multiple-myeloma/references/\">NICE, 2015a</a>].</li><li>The information on the percentage of people with multiple myeloma with negative serum and urine electrophoresis tests is based on expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/multiple-myeloma/references/\">BMJ Best Practice, 2018</a>].</li></ul><!-- end field 5c918244-29c0-4b6d-885d-bc6b5050db37 --><!-- end item ce033042-5494-4cdb-b0fb-e47d87abf1ba -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}